Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …

Background Cancer and multiple non-cancer conditions are considered by the Centers for
Disease Control and Prevention (CDC) as high risk conditions in the COVID-19 emergency. …

Objectives To estimate the impact of the COVID-19 pandemic on cancer care services and
overall (direct and indirect) excess deaths in people with cancer. Methods We employed near …

Genomic sequencing is rapidly transitioning into clinical practice, and implementation into
healthcare systems has been supported by substantial government investment, totaling over …

Nuclear factor kappa B (NF‐κB) activation has been proposed as a cardinal feature of
tumourigenesis, although the precise mechanism, frequency, relevance, and extent of NF‐κB …

Precision oncology relies on accurate discovery and interpretation of genomic variants,
enabling individualized diagnosis, prognosis and therapy selection. We found that six prominent …

Modern, affordable pathology and laboratory medicine (PALM) systems are essential to
achieve the 2030 Sustainable Development Goals for health in low-income and middle-income …

Cancer research is a crucial pillar for countries to deliver more affordable, higher quality,
and more equitable cancer care. Patients treated in research-active hospitals have better …

Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a
functioning health-care system at policy and governmental level, with the resultant inadequate …

Data from many preclinical studies, including those using cellular models of colorectal,
gastric, gastro-oesophageal and gastro-oesophageal junction cancers, indicate that the …